China Critical Care Services Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Critical Care Services Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Critical Care Services Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Critical Care Services Overall Market Size
2.1 China Critical Care Services Market Size: 2021 VS 2027
2.2 China Critical Care Services Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Critical Care Services Players in China Market
3.2 Top China Critical Care Services Companies Ranked by Revenue
3.3 China Critical Care Services Revenue by Companies
3.4 Top 3 and Top 5 Critical Care Services Companies in China Market, by Revenue in 2020
3.5 Companies Critical Care Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Critical Care Services Players in China Market
3.6.1 List of Tier 1 Critical Care Services Companies in China
3.6.2 List of Tier 2 and Tier 3 Critical Care Services Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Critical Care Services Market Size Markets, 2021 & 2027
4.1.2 Ventilator
4.1.3 Sphygmomanometer
4.1.4 Alarm
4.1.5 Other
4.2 By Type - China Critical Care Services Revenue & Forecasts
4.2.1 By Type - China Critical Care Services Revenue, 2016-2021
4.2.2 By Type - China Critical Care Services Revenue, 2022-2027
4.2.3 By Type - China Critical Care Services Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Critical Care Services Market Size, 2021 & 2027
5.1.2 Central Nervous System Failure
5.1.3 Circulatory Failure
5.1.4 Shock
5.1.5 Metabolic
5.1.6 Respiratory Failure
5.2 By Application - China Critical Care Services Revenue & Forecasts
5.2.1 By Application - China Critical Care Services Revenue, 2016-2021
5.2.2 By Application - China Critical Care Services Revenue, 2022-2027
5.2.3 By Application - China Critical Care Services Revenue Market Share, 2016-2027
6 Critical Care Services Companies Profiles
6.1 BioMed Central
6.1.1 BioMed Central Company Details
6.1.2 BioMed Central Business Overview
6.1.3 BioMed Central Critical Care Services Introduction
6.1.4 BioMed Central Critical Care Services Revenue in China Market (2016-2021)
6.1.5 BioMed Central Recent Developments
6.2 CSL Behring
6.2.1 CSL Behring Company Details
6.2.2 CSL Behring Business Overview
6.2.3 CSL Behring Critical Care Services Introduction
6.2.4 CSL Behring Critical Care Services Revenue in China Market (2016-2021)
6.2.5 CSL Behring Recent Developments
6.3 Takeda
6.3.1 Takeda Company Details
6.3.2 Takeda Business Overview
6.3.3 Takeda Critical Care Services Introduction
6.3.4 Takeda Critical Care Services Revenue in China Market (2016-2021)
6.3.5 Takeda Recent Developments
6.4 Grifols
6.4.1 Grifols Company Details
6.4.2 Grifols Business Overview
6.4.3 Grifols Critical Care Services Introduction
6.4.4 Grifols Critical Care Services Revenue in China Market (2016-2021)
6.4.5 Grifols Recent Developments
6.5 Kedrion Biopharma
6.5.1 Kedrion Biopharma Company Details
6.5.2 Kedrion Biopharma Business Overview
6.5.3 Kedrion Biopharma Critical Care Services Introduction
6.5.4 Kedrion Biopharma Critical Care Services Revenue in China Market (2016-2021)
6.5.5 Kedrion Biopharma Recent Developments
6.6 Octapharma
6.6.1 Octapharma Company Details
6.6.2 Octapharma Business Overview
6.6.3 Octapharma Critical Care Services Introduction
6.6.4 Octapharma Critical Care Services Revenue in China Market (2016-2021)
6.6.5 Octapharma Recent Developments
6.7 Bayer HealthCare
6.7.1 Bayer HealthCare Company Details
6.7.2 Bayer HealthCare Business Overview
6.7.3 Bayer HealthCare Critical Care Services Introduction
6.7.4 Bayer HealthCare Critical Care Services Revenue in China Market (2016-2021)
6.7.5 Bayer HealthCare Recent Developments
6.8 Merck
6.8.1 Merck Company Details
6.8.2 Merck Business Overview
6.8.3 Merck Critical Care Services Introduction
6.8.4 Merck Critical Care Services Revenue in China Market (2016-2021)
6.8.5 Merck Recent Developments
6.9 Mitsubishi Tanabe Pharma
6.9.1 Mitsubishi Tanabe Pharma Company Details
6.9.2 Mitsubishi Tanabe Pharma Business Overview
6.9.3 Mitsubishi Tanabe Pharma Critical Care Services Introduction
6.9.4 Mitsubishi Tanabe Pharma Critical Care Services Revenue in China Market (2016-2021)
6.9.5 Mitsubishi Tanabe Pharma Recent Developments
6.10 REVO Biologics
6.10.1 REVO Biologics Company Details
6.10.2 REVO Biologics Business Overview
6.10.3 REVO Biologics Critical Care Services Introduction
6.10.4 REVO Biologics Critical Care Services Revenue in China Market (2016-2021)
6.10.5 REVO Biologics Recent Developments
6.11 Rockwell Medical
6.11.1 Rockwell Medical Company Details
6.11.2 Rockwell Medical Business Overview
6.11.3 Rockwell Medical Critical Care Services Introduction
6.11.4 Rockwell Medical Critical Care Services Revenue in China Market (2016-2021)
6.11.5 Rockwell Medical Recent Developments
6.12 Thermo Fisher Scientific
6.12.1 Thermo Fisher Scientific Company Details
6.12.2 Thermo Fisher Scientific Business Overview
6.12.3 Thermo Fisher Scientific Critical Care Services Introduction
6.12.4 Thermo Fisher Scientific Critical Care Services Revenue in China Market (2016-2021)
6.12.5 Thermo Fisher Scientific Recent Developments
6.13 Shanghai RAAS
6.13.1 Shanghai RAAS Company Details
6.13.2 Shanghai RAAS Business Overview
6.13.3 Shanghai RAAS Critical Care Services Introduction
6.13.4 Shanghai RAAS Critical Care Services Revenue in China Market (2016-2021)
6.13.5 Shanghai RAAS Recent Developments
6.14 China Biologic Products
6.14.1 China Biologic Products Company Details
6.14.2 China Biologic Products Business Overview
6.14.3 China Biologic Products Critical Care Services Introduction
6.14.4 China Biologic Products Critical Care Services Revenue in China Market (2016-2021)
6.14.5 China Biologic Products Recent Developments
6.15 Cosmo Pharmaceuticals
6.15.1 Cosmo Pharmaceuticals Company Details
6.15.2 Cosmo Pharmaceuticals Business Overview
6.15.3 Cosmo Pharmaceuticals Critical Care Services Introduction
6.15.4 Cosmo Pharmaceuticals Critical Care Services Revenue in China Market (2016-2021)
6.15.5 Cosmo Pharmaceuticals Recent Developments
6.16 King Pharmaceuticals
6.16.1 King Pharmaceuticals Company Details
6.16.2 King Pharmaceuticals Business Overview
6.16.3 King Pharmaceuticals Critical Care Services Introduction
6.16.4 King Pharmaceuticals Critical Care Services Revenue in China Market (2016-2021)
6.16.5 King Pharmaceuticals Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Critical Care Services Market Opportunities & Trends in China Market
Table 2. Critical Care Services Market Drivers in China Market
Table 3. Critical Care Services Market Restraints in China Market
Table 4. Key Players of Critical Care Services in China Market
Table 5. Top Critical Care Services Players in China Market, Ranking by Revenue (2019)
Table 6. China Critical Care Services Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Critical Care Services Revenue Share by Companies, 2016-2021
Table 8. Companies Critical Care Services Product Type
Table 9. List of Tier 1 Critical Care Services Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Critical Care Services Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Critical Care Services Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Critical Care Services Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Critical Care Services Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Critical Care Services Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Critical Care Services Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Critical Care Services Revenue (US$, Mn), 2022-2027
Table 17. BioMed Central Company Details
Table 18. BioMed Central Business Overview
Table 19. BioMed Central Critical Care Services Product
Table 20. BioMed Central Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 21. BioMed Central Recent Developments
Table 22. CSL Behring Company Details
Table 23. CSL Behring Business Overview
Table 24. CSL Behring Critical Care Services Product
Table 25. CSL Behring Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 26. CSL Behring Recent Developments
Table 27. Takeda Company Details
Table 28. Takeda Business Overview
Table 29. Takeda Critical Care Services Product
Table 30. Takeda Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Takeda Recent Developments
Table 32. Grifols Company Details
Table 33. Grifols Business Overview
Table 34. Grifols Critical Care Services Product
Table 35. Grifols Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Grifols Recent Developments
Table 37. Kedrion Biopharma Company Details
Table 38. Kedrion Biopharma Business Overview
Table 39. Kedrion Biopharma Critical Care Services Product
Table 40. Kedrion Biopharma Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Kedrion Biopharma Recent Developments
Table 42. Octapharma Company Details
Table 43. Octapharma Business Overview
Table 44. Octapharma Critical Care Services Product
Table 45. Octapharma Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Octapharma Recent Developments
Table 47. Bayer HealthCare Company Details
Table 48. Bayer HealthCare Business Overview
Table 49. Bayer HealthCare Critical Care Services Product
Table 50. Bayer HealthCare Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Bayer HealthCare Recent Developments
Table 52. Merck Company Details
Table 53. Merck Business Overview
Table 54. Merck Critical Care Services Product
Table 55. Merck Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Merck Recent Developments
Table 57. Mitsubishi Tanabe Pharma Company Details
Table 58. Mitsubishi Tanabe Pharma Business Overview
Table 59. Mitsubishi Tanabe Pharma Critical Care Services Product
Table 60. Mitsubishi Tanabe Pharma Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Mitsubishi Tanabe Pharma Recent Developments
Table 62. REVO Biologics Company Details
Table 63. REVO Biologics Business Overview
Table 64. REVO Biologics Critical Care Services Product
Table 65. REVO Biologics Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 66. REVO Biologics Recent Developments
Table 67. Rockwell Medical Company Details
Table 68. Rockwell Medical Business Overview
Table 69. Rockwell Medical Critical Care Services Product
Table 70. Rockwell Medical Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Rockwell Medical Recent Developments
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Critical Care Services Product
Table 75. Thermo Fisher Scientific Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Thermo Fisher Scientific Recent Developments
Table 77. Shanghai RAAS Company Details
Table 78. Shanghai RAAS Business Overview
Table 79. Shanghai RAAS Critical Care Services Product
Table 80. Shanghai RAAS Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 81. Shanghai RAAS Recent Developments
Table 82. China Biologic Products Company Details
Table 83. China Biologic Products Business Overview
Table 84. China Biologic Products Critical Care Services Product
Table 85. China Biologic Products Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 86. China Biologic Products Recent Developments
Table 87. Cosmo Pharmaceuticals Business Overview
Table 88. Cosmo Pharmaceuticals Company Details
Table 89. Cosmo Pharmaceuticals Critical Care Services Product
Table 90. Cosmo Pharmaceuticals Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 91. Cosmo Pharmaceuticals Recent Developments
Table 92. King Pharmaceuticals Company Details
Table 93. King Pharmaceuticals Business Overview
Table 94. King Pharmaceuticals Critical Care Services Product
Table 95. King Pharmaceuticals Critical Care Services Revenue in China Market (2016-2021) & (US$ Million)
Table 96. King Pharmaceuticals Recent Developments
List of FiguresFigure 1. Critical Care Services Segment by Type
Figure 2. Critical Care Services Segment by Application
Figure 3. China Critical Care Services Market Overview: 2020
Figure 4. China Critical Care Services Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Critical Care Services Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Critical Care Services Revenue in 2020
Figure 7. By Type - China Critical Care Services Revenue Market Share, 2016-2027
Figure 8. By Application - China Critical Care Services Revenue Market Share, 2016-2027
Figure 9. BioMed Central Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. CSL Behring Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Takeda Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Grifols Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Kedrion Biopharma Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Octapharma Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Bayer HealthCare Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Merck Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Mitsubishi Tanabe Pharma Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. REVO Biologics Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Rockwell Medical Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Thermo Fisher Scientific Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Shanghai RAAS Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. China Biologic Products Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Cosmo Pharmaceuticals Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. King Pharmaceuticals Critical Care Services Revenue Year Over Year Growth (US$, Mn) & (2016-2021)